Prepair 500+
Gene: CPT2
From babyscreen+: Predominantly infantile onset, though milder presentation reported.
Treatment: bezafibrate, High-carbohydrate (70%) and low-fat (<20%) diet to provide fuel for glycolysis, carnitine, one third of the calories as even-chain medium chain triglycerides (MCT), triheptanoin (clinical trial published PMID 32885845)
CPT II deficiency, myopathic, stress-induced MIM#255110 can have onset in adolescence or adulthood and is triggered by exercise, fasting, or other metabolic stresses (OMIM)
Gene profile: The neonatal and severe infantile forms of CPTII deficiency have been associated with certain variants (c.1923_1935del, p.Pro227Leu, p.Asp328Gly) in exons 4 or 5. A clear genotype-phenotype correlation for the muscle form of CPTII is not currently known though majority of the variants are in exon 4 (PMID: 32295037, OMIM).Created: 1 Aug 2024, 4:08 p.m. | Last Modified: 1 Aug 2024, 4:08 p.m.
Panel Version: 1.76
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
CPT II deficiency, infantile MIM#600649; CPT II deficiency, lethal neonatal MIM#608836; CPT II deficiency, myopathic, stress-induced MIM#255110
Publications
Gene: cpt2 has been classified as Green List (High Evidence).
Phenotypes for gene: CPT2 were changed from CPT II deficiency, lethal neonatal, 608836 (3) to CPT II deficiency, infantile MIM#600649; CPT II deficiency, lethal neonatal MIM#608836
Publications for gene: CPT2 were set to
gene: CPT2 was added gene: CPT2 was added to Prepair 500+. Sources: Mackenzie's Mission,Expert Review Green Mode of inheritance for gene: CPT2 was set to BIALLELIC, autosomal or pseudoautosomal Phenotypes for gene: CPT2 were set to CPT II deficiency, lethal neonatal, 608836 (3)